Aspira Women's Health INC S-1 registration statements

Aspira Women's Health Inc. filed an S-1 registration statement for the resale of up to 16.7 million common shares by Lincoln Park Capital Fund, LLC, securing up to $10.0 million in committed equity financing.

Aspira Womens Health Inc. filed an S-1/A to register 29,226,527 shares of common stock for resale by existing stockholders, stemming from recent financing activities.

Aspira Women's Health Inc. filed an S-1 registration statement for the resale of 29,226,527 shares of common stock by existing selling stockholders, originating from convertible notes and warrants.

Aspira Women's Health is registering up to 42,683,030 shares for resale, including shares issued to Triton Funds LP, to support ongoing commercial activities and working capital.

Aspira Womens Health aims to raise up to $2 million through a common stock purchase agreement, as detailed in its amended S-1 filing.

Aspira Women's Health aims to raise up to $2 million through the resale of common stock by Triton Funds LP, as detailed in a recent SEC filing.

Aspira Women's Health aims to raise capital through a unit offering consisting of common stock and warrants, or pre-funded warrants and warrants, to fund working capital and general corporate purposes.

Aspira Womens Health is launching a public offering of up to 50 million units and 50 million pre-funded units to raise capital for working capital and general corporate purposes.

Aspira Women's Health is offering up to 16 million shares of common stock and pre-funded warrants to raise capital, while also facing potential delisting from the Nasdaq Capital Market.

Aspira Women's Health is registering for resale up to 1,571,000 shares of its common stock, issuable upon the exercise of warrants previously issued in a private placement.